{
    "Title": "Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease",
    "URL": "https://doi.org/10.1371/journal.pntd.0004014",
    "Published": "September 22, 2015",
    "Subject_Areas": [
        "Trypanosoma cruzi",
        "Chagas disease",
        "Drug discovery",
        "Parasitic diseases",
        "Sterols",
        "High throughput screening",
        "Drug screening",
        "Enzyme metabolism"
    ],
    "Authors": {
        "Jennifer Riley": [
            "Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, Dundee, United Kingdom"
        ],
        "Stephen Brand": [
            "Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, Dundee, United Kingdom"
        ],
        "Michael Voice": [
            "CYPEX, Dundee, United Kingdom"
        ],
        "Ivan Caballero": [
            "Molecular Discovery Research-Tres Cantos, GlaxoSmithKline, Centro de Investigaci칩n B치sica, Tres Cantos, Spain"
        ],
        "David Calvo": [
            "Molecular Discovery Research-Tres Cantos, GlaxoSmithKline, Centro de Investigaci칩n B치sica, Tres Cantos, Spain"
        ],
        "Kevin D. Read": [
            "Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, Dundee, United Kingdom"
        ]
    }
}